Exenatide has been shown to mitigate the phosphorylation of insulin receptor substrates and the accumulation of monomeric -synuclein
Furthermore, taking insulin or oral diabetes treatments, having a liver or renal illness, or taking certain medications may interact adversely with Semaglutide GLP-1
Coordinate multidisciplinary care among endocrinologists, obstetricians, and reproductive specialists to optimize timing of therapy and transition
Track what works for you with Shotsy Track daily calories, protein, fiber, and fat in Shotsy to see how your nutrition correlates with side effects and weight progress
Because food intake drops so significantly, theres a real risk of developing vitamin or nutrient deficiencies while on these medications
Potential Benefits and Risks of Microdosing GLP-1 Microdosing GLP-1 is proposed to reduce dose-dependent gastrointestinal side effects such as nausea and vomiting, but lacks randomised controlled trial evidence for efficacy or safety